Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study
Orphanet Journal of Rare Diseases · 17.08.2026 · 21 (1)
DOI: 10.1186/s13023-026-04534-9 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Orphanet Journal of Rare Diseases, online erschienen am 17.08.2026. Verfasst von Ya-Xin Guo und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Hospital of China Medical University, No.155 Nanjing Bei Street, Heping District, Shenyang, Liaoning Province, 1…. Hauptthemen laut MEDLINE: Neurofibromatosis 1. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenyang Youth Science and Technology Innovation Talents Support Program, the 111 Project, the National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Neurofibromatosis type 1 (NF1) is a rare autosomal dominant multisystem disorder caused by NF1 gene variants. Although NF1 shows marked clinical and genetic heterogeneity, large Chinese cohorts integrating clinical features, NF1 variant spectrum, and external variant contextualization remain limited.
Methods
We conducted a cross-sectional study of 847 clinically confirmed Chinese patients with NF1 to characterize demographic features, clinical manifestations, DNB-defined severity, and NF1 variant spectrum. Whole-exome sequencing was performed in 211 patients. Transcript-level variant distribution was assessed using a 500-bp sliding-window approach and further contextualized using ClinVar-derived NF1 variant data.
Results
Among 847 patients, the median age was 23 years, 27.5% had a family history of NF1, and more than 90% were younger than 40 years. Café-au-lait macules, neurofibromas, and plexiform neurofibromas were observed in 98.3%, 70.7%, and 20.9% of patients, respectively. Younger age, lower neurofibroma burden, and absence of learning difficulties were associated with DNB-defined mild classification. Among 211 genetically tested patients, pathogenic/likely pathogenic NF1 variants were identified in 182 patients, 11 carried NF1 variants of uncertain significance, and 18 had no reportable NF1 variant. In total, 152 distinct NF1 variants were identified, including 45 novel sites. Transcript-level analysis showed regional variation in reportable nucleotide-level NF1 variants, with relatively higher variant density around exons 10–15 and 44–49. Comparison with ClinVar pathogenic/likely pathogenic NF1 variants showed no significant window-level difference after multiple-testing correction.
Conclusions
This cross-sectional study summarizes the clinical and genetic features of Chinese patients with NF1 and expands the known NF1 variant spectrum in this population. Transcript-level analysis showed regional variation in reportable NF1 variants, broadly paralleling the ClinVar pathogenic/likely pathogenic NF1 variant distribution. These findings provide a basis for future longitudinal studies to validate clinically meaningful genotype–phenotype relationships in NF1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, The First Hospital of China Medical University, No.155 Nanjing Bei Street, Heping District, Shenyang, Liaoning Province, 110001, China.
- Key Laboratory of Immunodermatology, Ministry of Education and NHC, National joint Engineering Research Center for Theranostics of Immunological Skin Diseases, No.155 Nanjing Bei Street, Heping District,, Shenyang, Liao…
- Department of General Surgery, The Fourth Affiliated Hospital of China Medical University, Shenyang, China.
- Department of Social Medicine, College of Health Management, China Medical University, Shenyang, China.
- Department of Gynecology and Obstetrics, Shenyang Women and Children's Hospital, Shenyang, China.
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Shanghai Jiao Tong University, Ministry of Education, Shanghai, China.
Förderung
- Shenyang Youth Science and Technology Innovation Talents Support Program
- the 111 Project
- the National Key Research and Development Program of China
- National Natural Science Foundation of China
- the Clinical Research Grant Program of the Beijing Society of Integrative Medicine
- Liaoning Provincial Office of Philosophy and Social Science
Zitieren
APA
Guo, Y. X., Liu, X. D., Yan, Y. Q., Wang, H. X., Yang, X. S., Lv, Y., Ma, G., Croitoru, D., Qi, R. Q., Wu, Y., Xiao, T., Geng, L., Piguet, V., Chen, H. D., Legius, E., Xu, X. G., & Gao, X. H. (2026). Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study. Orphanet Journal of Rare Diseases, 21(1). https://doi.org/10.1186/s13023-026-04534-9
Vancouver
Guo YX, Liu XD, Yan YQ, Wang HX, Yang XS, Lv Y, et al. Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study. Orphanet Journal of Rare Diseases. 2026;21(1). doi:10.1186/s13023-026-04534-9
BibTeX
@article{Guo2026,
author = {Guo, Ya-Xin and Liu, Xin-De and Yan, Yi-Qiu and Wang, He-Xiao and Yang, Xiao-Shi and Lv, Yuan and Ma, Gang and Croitoru, David and Qi, Rui-Qun and Wu, Yan and Xiao, Ting and Geng, Long and Piguet, Vincent and Chen, Hong-Duo and Legius, Eric and Xu, Xue-Gang and Gao, Xing-Hua},
title = {Clinical characteristics and variant spectrum of NF1 in Chinese patients with neurofibromatosis type 1: a cross-sectional study},
journal = {Orphanet Journal of Rare Diseases},
year = {2026},
volume = {21},
number = {1},
doi = {10.1186/s13023-026-04534-9}
}
EUVIMED